טוען...
Regulatory B cell production of IL-10 inhibits lymphoma depletion during CD20 immunotherapy in mice
Current therapies for non-Hodgkin lymphoma commonly include CD20 mAb to deplete tumor cells. However, the response is not durable in a substantial proportion of patients. Herein, we report our studies in mice testing the hypothesis that heterogeneity in endogenous tissue CD20(+) B cell depletion inf...
שמור ב:
| Main Authors: | , , , |
|---|---|
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
American Society for Clinical Investigation
2011
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3204847/ https://ncbi.nlm.nih.gov/pubmed/22019587 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1172/JCI59266 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|